J Korean Med Sci.  2022 Jul;37(29):e240. 10.3346/jkms.2022.37.e240.

To Prescribe, or Not to Prescribe, That Is the Question

• Rhee CK

• KMID: 2532091
• DOI: http://doi.org/10.3346/jkms.2022.37.e240

Reference

1. Min J, Ko Y, Kim HW, Koo HK, Oh JY, Jeong YJ, et al. Increased healthcare delays in tuberculosis patients during the first wave of COVID-19 pandemic in Korea: a nationwide cross-sectional study. J Korean Med Sci. 2022; 37(3):e20. PMID: 35040295.

2. Dambroso-Altafini D, Dos Santos Saalfeld SM, de Souza Ferreira de Mattos M, Martinez HV, Shinohara DR, Zarpellon MN, et al. Overuse of empirical antibiotics in a COVID-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital. J Glob Antimicrob Resist. 2022; 30:100–102. PMID: 35710060.

3. Kang Y, Chen S, Chen Y, Tian L, Wu Q, Zheng M, et al. Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure. Int J Hyg Environ Health. 2022; 240:113882. PMID: 34915282.

4. Galang-De Leon WAM, Buensalido JAL. Prevalence of empiric antibacterial therapy, community-acquired bacterial superinfection, and antibiotic-associated adverse reactions among patients with COVID-19 pneumonia admitted in makati medical center from March 2020 to March 2021. Infect Chemother. 2022; 54(2):266–274. PMID: 35706084.

5. Takazono T, Mukae H, Izumikawa K, Kakeya H, Ishida T, Hasegawa N, et al. Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: a nationwide survey by the Japanese Respiratory Society. Respir Investig. 2022; 60(1):154–157.

6. Puzniak L, Bauer KA, Yu KC, Moise P, Finelli L, Ye G, et al. Effect of inadequate empiric antibacterial therapy on hospital outcomes in Sars-Cov-2-positive and -negative us patients with a positive bacterial culture: a multicenter evaluation from March to November 2020. Open Forum Infect Dis. 2021; 8(6):ofab232. PMID: 34141818.

7. Park DH, Lee CM, Chang E, Kang CK, Park WB, Kim NJ, et al. Clinical impact of empirical antibiotic therapy in patients with coronavirus disease 2019 requiring oxygen therapy. J Korean Med Sci. 2022; 37(29):e238.

8. Pettit NN, Nguyen CT, Lew AK, Bhagat PH, Nelson A, Olson G, et al. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission. BMC Infect Dis. 2021; 21(1):516. PMID: 34078301.